Podcasts about cme

Guy & Dan set you up for this week in markets, after the break Bill Capuzzi (CEO of Apex Fintech Solutions) & Tom Sosnoff (CEO of LossDog) join the pod. The guys describe Apex's role as core market infrastructure serving nearly 40 million accounts, the global growth and rising sophistication of retail options trading, AI's impact on fraud reduction and operational friction, Sosnoff's new venture Lossdog and AI focus, and both critique prediction markets' fee structure, conflicts, and looming regulatory reconciliation. Show Notes US intervention in oil futures would be ‘biblical disaster', CME warns (FT) Schwab CEO Says Markets-Savvy Gen Z Joins Dip-Buying Frenzy (Bloomberg) —FOLLOW USYouTube: @RiskReversalMediaInstagram: @riskreversalmediaTwitter: @RiskReversalLinkedIn: RiskReversal Media

Dr Ravin Ratan from The University of Texas MD Anderson Cancer Center in Houston discusses available clinical data with treatment approaches for desmoid tumors, alongside clinical cases illustrating real-world application.CME information and select publications here.

Featuring perspectives from Dr Haley Ellis, Prof Eric Van Cutsem and Dr Zev Wainberg, moderated by Dr Lionel A Kankeu Fonkoua, including the following topics: Biliary tract cancer progressing on first-line therapy (0:00) Gallbladder cancer (5:01) Biliary tract cancer with multiple biomarker targets (8:52) CME information and select publications

Dr Haley Ellis from Mass General Brigham Cancer Institute in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data and provide their perspectives on the management of HER2-positive GI cancers.CME information and select publications here.

Downtown Chicago apartment rents keep climbing as new supply lags. Crain's commercial real estate reporter Rachel Herzog talks about the downtown rental outlook with host Amy Guth. Plus: City Council budget coalition blocks local video gambling bans, Chicago urges FAA to rethink its plans to cut summer flying at O'Hare, CME and Cboe chiefs urge crackdown on fast-growing prediction markets and airlines brace for turmoil as fuel costs surge amid war in the Middle East. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Featuring an interview with Dr Bijal Shah, including the following topics: Advent and importance of blinatumomab in the therapeutic landscape of acute lymphoblastic leukemia (ALL) (0:00) Similarities and differences between bispecific T-cell engagers (BiTEs) and bispecific antibodies (5:51) Rationale underlying the development of surovatamig and MK-1045; benefits of blinatumomab for patients without detectable minimal residual disease (9:56) Extramedullary ALL, including in the CNS (13:32) Key principles in the development and use of surovatamig and MK-1045, including structural features and recent efficacy and safety findings (18:34) Ongoing immunotherapy trials for ALL, including studies of BiTEs and chimeric antigen receptor T-cell therapy (25:37) Case: A woman in her late 50s with newly diagnosed Philadelphia chromosome-positive B-cell ALL and multiple comorbidities (31:48) Case: A woman in her early 50s with newly diagnosed B-cell ALL, a TP53 mutation and significant extramedullary disease including the CNS (41:16) Case: A man in his early 50s with intermediate-risk B-cell ALL who receives surovatamig on a clinical trial (53:05) CME information and select publications

Dr Bijal Shah from Moffitt Cancer Center in Tampa, Florida, discusses the role of BiTEs in the management of ALL.CME information and select publications here.

In this episode, Sam Ashoo, MD and Dr. Dana Klavansky, MD discuss the March 2026 Emergency Medicine Practice article, Emergency Department Evaluation and Management of Severe Traumatic Brain InjuryIntroduction & Welcome (0:15)Guest Introduction (0:55)Epidemiology of Severe TBI (2:37)Pathophysiology: Primary vs. Secondary TBI (4:24)Types of Hemorrhage and Hematomas (5:25)Classification (7:31)Mild vs. Moderate vs. Severe TBIImpact Loading vs. Inertial LoadingDifferential Diagnosis (9:22)Prehospital Care (9:42)Emergency Department History (13:33)Diagnostics (15:13)CT Scan and the A-B-B-B-C ApproachRepeat CT TimingBedside Ultrasound for Optic Nerve Sheath DiameterPupillometryBiomarkersTreatment (24:52)Airway ManagementVentilation and CO2 TargetsHyperosmolar Therapy: Hypertonic Saline and MannitolCerebral Perfusion PressureBlood Pressure GoalsTemperature ManagementCoagulopathy ManagementSeizure Prophylaxis and EEG MonitoringTiered ICP Management (35:29)Surgical Indications (38:40)Prognosis (40:33)Special Topics (41:30)Sports Injuries and CTETranexamic Acid (CRASH-3 Trial)Wrap-Up (43:46)Subscribers, take the CME test here. Emergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

BEEF: I've been saying for a few weeks now it would not be a bad idea to keep well ahead of your needs. I'm doubling down on this as the reduced production we've seen this year is impacting product availability and pricing. Inventories will be tighter still with reduced production and increasing demand. Last week's harvest was 521k head, running a full 10% behind last year's reduced production. Markets are responding hard to this tight inventory, everything, I mean everything is moving higher. Led by middle meats, ribeyes, tenderloins, and strip loins, but all cuts are seeing increases. I've seen a couple analysts have the opinion this surge will scare off consumers and turn back down. I hope they are right and I'm wrong, but right now all I see in increases and strong demand. I'd buy now, waiting will cost you money.Chicken will be the alternate protein of choice for consumers moving from higher priced beef. Wings are lower a third week, I don't see this lasting much longer while boneless skinless randoms and tenders are moving higher. I do expect chicken increases to continue. Proudction is running about 2% ahead of last year and demand is keeping the product moving.On the Avian Flu front, another difficult week, 20 new cases reported affect 3.5 million birds, mostly egg layers. The northern migration is in full swing now, I do hope we get some relief soonSoy and canola have another strong week moving higher. Its been so long since we've seen a bull market in soy oil but demand and moving product to biofuels has spurred this market higher. Not so for corn and wheat continuing to trade sideways.Pork bellies leveled off at $153 same as last week. Bacon prices will be moving up but hopefully we get a few weeks breather. Loins, butts, ribs, all still a good value. Pork continues to be a great protein value.The dairy market went on a tear last week, giving back almost all the gains this week. As of Thursday's CME close, butter is down 16, barrel and block are both down 2. We'll see what next week brings.Savalfoods.com | Find us on Social Media: Instagram, Facebook, YouTube, Twitter, LinkedIn

Julie Dirksen is the author of the books Design For How People Learn and Talk to the Elephant: Design Learning for Behavior Change. She is a learning strategy consultant with a focus on incorporating behavioral science into learning interventions. Her MS degree is in Instructional Systems Technology from Indiana University. She's been an adjunct faculty member at the Minneapolis College of Art and Design and is a Learning Guild Guildmaster. She is happiest when she gets to learning something new, and you can find her at usablelearning.com.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

We've spoken with many guests about clinical and technological trends impacting healthcare providers, but less so about the trends on the business side of practicing medicine.  So on this episode, we're going to make up for that by spending our time with Dr. Alexander Vaccaro, an influential spine surgeon and president of one of the largest musculoskeletal practices in the U.S. -- Rothman Orthopaedic Institute -- which treats patients at over 40 locations in Pennsylvania, New Jersey, New York and Florida. While Dr. Vaccaro understands the desire for financial stability that's increasingly driving young physicians into the arms of hospital systems, he worries about what's being lost with the resulting decline in the number of independent practices.  “If you didn't have private practice advocating for the doctor, the insurance companies would bully the healthcare profession.” Join Raise the Line host Michael Carrese for a candid and lively conversation that also covers: How physician autonomy and entrepreneurship can drive innovation; The economic and policy forces reshaping private practice medicine; The role of research partnerships between private practices and universities. Mentioned in this episode:Rothman Orthopaedics If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Featuring a slide presentation and related discussion from Dr Bijal Shah, including the following topics: Historical approaches to managing acute lymphoblastic leukemia, their limitations and present approaches to treatment (0:00) Mechanistic approach underlying blinatumomab; key clinical trial data and their implications (7:29) Mechanistic approaches underlying surovatamig and MK-1045; dosing and administration strategies with various bispecific T-cell engagers (23:27) Key clinical trial data with surovatamig; implications for practice (32:38) Key clinical trial data with MK-1045; implications for practice (39:02) Synthesizing and comparing data across subcutaneous blinatumomab, surovatamig and MK-1045 (42:36) CME information and select publications

Welcome to Perimenopause WTF!, brought to you by ⁠Perry⁠—the #1 perimenopause app and education space. The Perry Academy was created for

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TPK865. CME credit will be available until March 11, 2027.Disease and Disability Progression in Relapsing MS: Unpacking Efficacy Data to Advance Treatment DecisionsThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.SupportThis independent Satellite Symposium is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TPK865. CME credit will be available until March 11, 2027.Disease and Disability Progression in Relapsing MS: Unpacking Efficacy Data to Advance Treatment DecisionsThe University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.SupportThis independent Satellite Symposium is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

Neuroendocrine tumor (NET) care is changing fast—and the pace of innovation is only accelerating. In this episode, Aman Chauhan, MD, Associate Professor of Clinical Medicine at the University of California, San Francisco (UCSF), breaks down the latest advances that are reshaping how clinicians diagnose and treat NETs. Dr. Chauhan, who recently chaired i3 Health's CME activity Optimizing Neuroendocrine Tumor Outcomes: Closing the Gaps in Diagnosis and Care, returns to highlight what's new and what matters most for practice. From evolving epidemiologic insights to emerging targeted therapies and next‑generation immunotherapies, he explains how these developments are expanding options for patients and refining real‑world decision making. Whether you're a clinician treating NETs, a trainee looking to stay current, or a listener interested in where cancer care is headed next, this conversation offers a concise, high‑yield tour of the NET landscape—and where it's going next. Click the link to view the full activity and claim your free CME credit: https://bit.ly/41Qo65Y Click here to download/view the infographic: https://bit.ly/4bbSUmL

Featuring an interview with Prof Constantine Tam, including the following topics: Evolving first-line treatment paradigm for patients with previously untreated chronic lymphocytic leukemia (CLL) (0:00) Considerations for the administration of first-line venetoclax-based regimens (3:24) Mechanism of action of sonrotoclax and observed early-phase efficacy in combination with zanubrutinib; minimal residual disease as a potential clinical trial endpoint (10:01) Continuous versus fixed-duration first-line treatment approaches for previously untreated CLL (14:38) Selecting between up-front acalabrutinib- and zanubrutinib-based time-limited therapy options (19:07) Up-front treatment selection for patients with del(17p) CLL (24:01) Stopping and restarting acalabrutinib for frail patients with previously untreated CLL (26:43) Pirtobrutinib for treatment-naïve and relapsed/refractory CLL/small lymphocytic lymphoma: Results from the Phase III BRUIN CLL-314 and BRUIN CLL-313 trials (30:20) Lisocabtagene maraleucel as treatment for patients with double-refractory CLL (37:00) Perspectives on future roles of novel therapies and treatment strategies (43:11) CME information and select publications

Prof Constantine Tam from Monash University in Melbourne, Australia, reviews recent datasets and discusses their implications for current and future management of chronic lymphocytic leukemia.CME information and select publications here.

NESTA EDIÇÃO. Petrobras abre disputa por diesel no Rio Grande do Sul em meio a corrida do mercado por estoques. Novo presidente da CME defende aprovar encargo na geração distribuída para reduzir peso nas contas de luz. Diretor-geral da ANP diz que gas release não deve ignorar papel da Petrobras no aumento da oferta. Governo prepara plano para enfrentar aumento do calor extremo. ***Locução gerada por IA

What if mastering communication in your marriage as a physician could be as transformative as learning a life-saving procedure in residency?  In this second part of a two-part conversation, Dr. Michael Myers shares insights from his extensive experience treating physician couples, emphasizing the value of professional help in facilitating communication during protected times like retreats or dates. He illustrates how a third party can help rephrase defensive or hierarchical language, common in medicine's decisive environment, into softer, more effective expressions, such as turning "you're stubborn" into "I feel you're digging in your heels," to foster understanding without offense.  Dr. Myers discusses dynamics when the physician is female, noting women's multifaceted identities beyond medicine and potential role reversals where husbands manage home life, but warns of conflicts arising from feelings of being taken for granted or loneliness. He highlights red flags like unexplained drinking or affairs, urging early articulation of issues to prevent escalation, and notes that most couples recover from affairs by entering a "new normal" with professional guidance.  For same-sex couples, he addresses communication stereotypes: avoidance in male pairs or overthinking in female ones, while stressing commonalities in all relationships. In dual-physician marriages, intellectualization may dominate, but reviewing arrangements like part-time work during child-rearing years and supporting paternity leave promotes respect and balance. Parting tips include finding uninterrupted time, transitioning from work mode, taking risks by being vulnerable about insecurities, and converting individual therapy into couples work to avoid exclusion.  Three Actionable Takeaways: Seek professional facilitation for tough conversations: Use a therapist to rephrase defensive language and ensure both partners feel heard, preventing escalation into arguments or name-calling. Regularly review relationship dynamics: Check in on sacrifices like relocations or part-time work, honoring promises and expressing appreciation to avoid resentment or feelings of being sidelined. Take communication risks during protected time: Be vulnerable about insecurities or feelings, such as loneliness, to deepen connection, and avoid defaulting to safe topics, use this safe space to address meaningful issues. About the Show: Succeed In Medicine covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school! About the Guest: Dr. Michael F. Myers is a professor of clinical psychiatry and recent past vice president of education and director of training in the Department of Psychiatry and Behavioral Sciences at SUNY Downstate Health Sciences University in Brooklyn. He's a specialist in physician health and the author of many books, including "Physicians with Lived Experience: How Their Stories Offer Clinical Guidance" and "Doctors' Marriages: A Look at the Problems and Their Solutions." He lectures widely on stresses in medical training, burnout, moral injury, depression, substance use, PTSD, marital discord, and reducing stigma in medicine. Connect with Dr. Michael Myers: Website: https://www.michaelfmyers.com About the Host: Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physicians Want to be a guest? Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more! Socials: @physiciansguidetodoctoring on Facebook @physicianguidetodoctoring on YouTube @physiciansguide on Instagram and Twitter   This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Five-Day Weekend: Retirement Planning and Practice Legacy for PediatriciansIn this Pediatric Lounge episode, hosts discuss Nicholas Children's upcoming postgraduate pediatrics CME conference and then interview repeat guest Dr. Neil Bevin of RBK Pediatrics about physician retirement. Bevin describes planning a year ahead to transition administrative responsibilities, defining financial independence based on cost of living, and how taxes affect retirement withdrawals. He highlights common mistakes such as underfunding retirement in peak earning years, failing to adapt practice models as pediatrics shifts toward chronic disease management, and retaining control too long, which can damage practice value and legacy. He explains RBK's move from a defined benefit plan to a 401(k) and Roth options, notes limited retirement participation among younger employees, and discusses private equity's impact on job security and pensions. Bevin shares his semi-retired “five-day weekend” schedule, stresses planning hobbies and purpose, recommends saving early (including 529 plans), and emphasizes leaving unhealthy practices, avoiding divorce, and using keyman insurance in small practices.00:00 Podcast Intro and CME Plug00:50 Snowy Weekend Banter01:27 Meet Dr Neil Bevin02:07 Planning the Exit04:42 Financial Independence Basics06:17 How Much Is Enough07:17 Common Retirement Mistakes10:42 Practice Legacy and Adaptation16:33 Giving Up Control18:46 Retirement Mindset and Hobbies21:42 401k and Roth Basics23:30 Pensions and Private Equity Risks26:29 The Five Day Weekend27:36 Fair Scheduling Mindset28:11 Flexibility Beats Absolutes28:20 529 Plans For Kids30:21 Inflation Crushing Doctors32:36 Law Pay Versus Pediatrics35:07 Private Equity Job Risk38:26 Starting A Practice Today39:30 Mortgage And Refi Strategy42:42 Retirement Advice By Age45:11 Keyman Insurance Matters46:43 Practice Culture Horror Story49:11 Wrap Up And CreditsSupport the show

Featuring a slide presentation and related discussion from Prof Constantine Tam, including the following topics: Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia (CLL): Results from the randomized CLL17 trial (0:00) Six-year follow-up data from the Phase III SEQUOIA trial of zanubrutinib for patients with treatment-naïve CLL and those with del(17p) CLL not randomly assigned (4:59) Primary endpoint analysis of the randomized STAIR trial of time-limited acalabrutinib monotherapy for frail patients with previously untreated CLL (7:25) Safety analyses of acalabrutinib/venetoclax (AV) or AV in combination with obinutuzumab for previously untreated CLL (10:50) Three-year results with zanubrutinib combined with venetoclax in arm D of the Phase III SEQUOIA trial for treatment-naïve CLL (17:15) Early-phase data with sonrotoclax combinations as front-line treatment of CLL (19:12) Pirtobrutinib for treatment-naïve and relapsed/refractory CLL/small lymphocytic lymphoma: Results from the Phase III BRUIN CLL-314 and BRUIN CLL-313 trials (23:27) Long-term extension (LTE1) results from the Phase III ALPINE trial of zanubrutinib versus ibrutinib in patients with relapsed/refractory CLL or small lymphocytic lymphoma (R/R CLL/SLL) (28:53) Updated efficacy and safety results of the Bruton tyrosine kinase degrader BGB-16673 in patients with R/R CLL/SLL from the ongoing phase 1 CaDAnCe-101 study (30:35) Real-world outcomes of lisocabtagene maraleucel in CLL (33:04) CME information and select publications

Send a textThere are few moments in a growing medical practice that feel more uncomfortable than this one.You look around and realize that something isn't working the way it used to. Day-to-day operations feel harder. Decisions seem slower. Issues keep landing back on the physicians' desks. And yet, the person at the center of it all—the office manager—has been loyal, hardworking, and instrumental in getting the practice to where it is today.This is where leadership and loyalty collide.Today, we're talking about a common growing pain in medical practices: when a good office manager isn't enough anymore. Not because they failed. Not because they didn't care. But because the practice changed—and the role didn't.There's a phrase that comes up again and again in these situations: what got you here won't get you there. And nowhere is that more true than in practice management.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: https://share.hsforms.com/1FMup6xLPSpeA8hB77caYQwd32sx?hsCtaAttrib=171926995377 Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Promo pricing available now: https://education.healtheps.com/offers/Ry3zfLYp/checkout?coupon_code=PHYSEDGE3000  Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

Get Dr. Vonda's latest insights on strength, bone health, longevity, and aging with power delivered straight to your inbox. Join her free health & longevity newsletter here: https://www.drvondawright.com/resources/aging-longevity   You only build bone during deep sleep, and only if you get enough of a growth hormone spike to make it happen. As someone who has spent her career fighting osteoporosis, I had never connected those dots that clearly before. Morning light, deep sleep, and bone density are part of the same biological chain. That alone is worth the listen. This week, I am joined by Dr. John La Puma, the originator of culinary medicine. After reviewing over 2,200 studies for his new book, Indoor Epidemic, his conclusion is both sobering and actionable: we are spending 93% of our lives indoors, and our biology is paying for it in ways most of us cannot even perceive. Fatigue. Brain fog. Disrupted sleep. Accelerated aging. And we keep reaching for supplements and prescriptions when the answer is often just outside the door. What we cover: - Why 93% of our time indoors is a biological emergency quietly aging us faster from the inside out. - How 10 to 15 minutes of morning light resets your circadian clock and primes your body for deep, restorative sleep. - Why screen light within 30 minutes of bedtime drops melatonin by 20%, no matter what else you did right. - How deep sleep triggers the growth hormone spike your body needs to build bone, making it a frontline tool against osteoporosis. - Why green exercise feels 20% easier and drops cortisol by 21% when done in a place of your choice. - What digital obesity really means and why too many pixels burn out your brain the same way too much sugar burns out your metabolism. - How one hour of gardening a week can lower hemoglobin A1C by 0.5%, roughly equal to a starting dose of metformin. - What the Louisville Green Heart Study found, including a 22% drop in CRP, when greenery came to a community. - Why two to five intentional hours outdoors each week can give you up to five years of health span back.   About Dr. John La Puma: Dr. John La Puma is an academic clinician, trained chef, and organic farmer recognized as the originator of culinary medicine. He runs a certified organic educational farm in Santa Barbara and led the first CME course in the country teaching physicians to use nature as medicine. Indoor Epidemic is his distillation of 2,200 studies into a practical guide for reclaiming your biology. Connect with Dr. John La Puma: Website: https://www.drjohnlapuma.com/ Instagram: https://www.instagram.com/johnlapuma/   Timestamps 00:00 Intro 01:30 Culinary Medicine, Organic Farming and the Origin of a Field 03:30 The Indoor Epidemic: Why 93% Indoors Is a Biological Emergency 07:00 How 10 to 15 Minutes Resets Your Entire Biology 11:00 Screens, Melatonin and the 30-Minute Rule Before Bed 13:30 How Your Brain Cleans Itself During Deep Sleep 17:00 Why Over 50% of Your Genes Run on a Body Clock 20:00 20% Less Effort and a 19% Reduction in Mortality 24:00 Digital Obesity and What Ultra-Processed Time Is Doing to Your Brain 28:00 Indoor Air, Toxins, Carbon Dioxide and the Invisible Cognitive Drain 32:00 Chronic Inflammation, Telomere Shortening and Premature Aging 34:00 Greenery, CRP and Cardiovascular Health 38:30 Gardening, Hemoglobin A1C and the Metformin Comparison 41:00 Deep Sleep and Bone Building 44:30 The Biggest Barrier to Change and Why Knowledge Comes First 46:30 Two to Five Hours Outdoors a Week Can Add Five Years to Your Health Span  

What are collectivist cultures? How is childhood well-being impacted by the culture a person grow up in?In this series on healthcare and social disparities, Dr. Jill Wener, a board-certified Internal Medicine specialist, anti-racism educator, allyship coach, meditation expert, and tapping practitioner, interviews experts and gives her own insights into multiple fields relating to social justice and anti-racism. In this episode, Jill interviews Agatha Peters, a Nigerian-American psychotherapist. They discuss the cycle of abuse with narcissistic parents, how that can show up in certain cultures, and how to interrupt that cycle. A Nigerian-American psychotherapist, Agatha Peters is the founder of Beautiful Sunshine Therapy and the author of Trapped in Their Script: Reclaim Your Life from Narcissistic Parents & Cultural Expectations. She is dedicated to helping adult children of narcissistic parents, especially those from collectivist cultures, where family loyalty often overshadows individual well-being. Having experienced the healing power of therapy herself, she is passionate about helping others discover the same transformation and offers guidance on embracing one's identity while respecting cultural ties.LINKShttps://beautifulsunshinetherapy.com**Our website www.consciousantiracism.comYou can learn more about Dr. Wener and her online meditation and tapping courses at www.jillwener.com, and you can learn more about her online social justice course, Conscious Anti Racism: Tools for Self-Discovery, Accountability, and Meaningful Change at https://theresttechnique.com/courses/conscious-anti-racism.If you're a healthcare worker looking for a CME-accredited course, check out Conscious Anti-Racism: Tools for Self-Discovery, Accountability, and Meaningful Change in Healthcare at www.theresttechnique.com/courses/conscious-anti-racism-healthcareJoin her Conscious Anti-Racism facebook group: www.facebook.com/groups/307196473283408Follow her on:Instagram at jillwenerMDLinkedIn at jillwenermd

Meet the Fantastic—and Controversial—Dr. David Healy Psychiatric Drug Companies-- What Are They NOT Telling Us? Today, we are thrilled to interview the famed and courageous Dr. David Healy. I have admired his work for many years, but never imagined I'd have the chance to meet him and chat with him. First things first. You may know Dr. David Healy for some of his highly controversial books, like "The Antidepressant Era," "Let Them Eat Prozac," and "Pharmageddon." But who is he, really? According to AI, Dr. David Healy is a prominent Welsh psychiatrist, psychopharmacologist, and critic of the pharmaceutical industry known for his research on antidepressants, their links to suicide, and exposing industry practices like ghostwriting and disease-mongering, operating through initiatives like RxISK.org to promote drug safety. He has a long history of challenging Big Pharma, facing academic backlash (like losing a University of Toronto post) for his views, and serving as an expert witness in legal cases involving psychotropic drugs, advocating for greater transparency and patient safety.  Healy initially worked with pharmaceutical companies, gaining firsthand knowledge of how SSRIs were marketed despite their trial weaknesses, focusing on the oversimplified serotonin hypothesis. He then became a vocal critic, highlighting issues like ghostwriting articles and manipulating academic opinion to sell drugs, leading to conflicts with industry-funded institutions. He founded RxISK.org, a platform for patients to report adverse drug reactions, aiming to make medicines safer. His strong stance (on research linking SSRI antidepressants to increased suicidal thoughts and urges) led to intense and corrosive controversy, including losing a professorship at the University of Toronto (though later settled as a visiting role) and harassment, noted here and here. In recent years, he has acted as an expert witness in cases involving drug-related suicides and homicides, bringing issues to regulators.  In essence, Dr. David Healy is a significant, often controversial, figure dedicated to drug safety, academic integrity, and patient awareness in psychiatry, challenging established narratives and industry power.  Taking a deeper dive, AI has added this critically important information: David Healy has discussed numerous examples of conflicts of interest that mainly involve the influence of the pharmaceutical industry on medical research, publication, and practice.  Key examples he has highlighted include: Ghostwriting of Articles: Pharmaceutical companies hire medical communication firms to draft research articles or reviews, and then get prominent academics or clinicians to put their names on the papers as the sole or primary authors, a practice known as ghostwriting. The named authors often have little to no involvement in the actual research or writing. Hiding or Misrepresenting Data: Drug companies have concealed unfavorable data or miscoded raw data on drug risks, such as the link between antidepressants and suicidal acts. This manipulation can make a drug appear safer or more effective than it actually is. Biased Clinical Trial Design: Healy notes instances where clinical trials are designed with "tricks," such as using inadequate or excessive doses of comparison medications to make the company's own drug look superior. Marketing-Driven Education: A large portion of continuing medical education (CME) classes for doctors are sponsored by industry. Healy argues this leads to a bias in the information presented to doctors, with an emphasis on the benefits of brand-name drugs rather than an objective assessment of all treatment options. Gifts and Payments to Physicians: Drug companies spend billions annually on marketing directed at doctors, including free samples, sales visits, and small non-educational gifts or lunches. Healy points out that while many doctors believe these gifts don't affect their own prescribing, studies show they influence prescribing patterns and create subtle biases. Industry Influence on Academia: Healy's own experience with a job offer being rescinded at the University of Toronto, which had received a large donation from a drug company (Eli Lilly), is a prominent case he uses to illustrate how industry funding can infringe upon academic freedom and stifle critical research. "Disease Mongering": Healy argues that the pharmaceutical industry often engages in "disease mongering," marketing conditions to the public and physicians to create a market for their products rather than simply addressing genuine medical needs.  So that hopefully gives you some idea of the scope of his work, and his vision of transparency and integrity in the reporting one the effectiveness and risks of psychotropic medications. In our conversation today, he emphasized the importance of listening to patients who describe side effects of medications, such as SSRIs, in described the efforts of Big Pharma to suppress such complaints, giving psychiatrists "talking points" to reassure and quiet concerned patients. In general, a main focus of his career has been to challenge and confront the efforts of drug companies to suppress negative information about their products and troublesome and dangerous side effects. He said that one of the rationales the drug companies use is to say that disseminating that type of information will discourage many potential patients from using their products, and therefore miss out on the potential benefits of the medications. In fact, they have a name for this, "treatment hesitancy," and discourage open discussion of negative effects for this reason. I asked Dr. Healy if he's experienced direct negative pushback from drug companies, and he gave a surprising answer—he said no, that the major pushback he's gotten has actually been from colleagues—psychiatrists who have bought the party line disseminated by the drug manufactures. For example, when he gave his famous talk at the University of Toronto on the increase in suicidal urges associated with SSRI antidepressants, a famous psychopharmacologist, Dr. Charlie Nemeroff, got him fired. Here's the story on Dr. Nemeroff, According to AI: In the late 2000s, Nemeroff faced investigations and sanctions from Emory University for failing to disclose significant speaking and consulting fees from pharmaceutical companies like GlaxoSmithKline, raising questions about research integrity and conflicts of interest, notes The BMJ and The New York Times.  Although the antidepressant effects of SSRIs are controversial and hotly debated, their effects on the nervous system are not. Dr. Healy's research indicates that they have a suppression effect on the nervous system, which dulls the senses, and this can happen within 1 to 2 days. One of the more troublesome of these effects is called "genital numbing," which affects 9 out of 10  people talking SSRIs. This can result in difficulties with sexual arousal and greatly delayed orgasm, and apparently these effects can persist long after drug discontinuation. He said that these sensory effects can develop quickly, within a day or two of starting the medications. Even more chilling, he said that the problem can actually get worse when you discontinue the medication, and can sometimes persist for life. In addition, quite a few individuals have "bad trips" on SSRIs, although a minority clearly have "good trips." He said the best thing to do for a bad trip is to take the patient off of the medication immediately—and NOT increase the dose. He confirmed my impression that a common error with all antidepressants is to increase the dose—which simply increases the side effects. In addition to the genital numbing described above, he said the SSRIs cause "emotional numbing," which means a decreased capacity for joy as well as sorrow. One of the main activities in David Healy's life has been listening to patients, rather than discounting their complaints when they describe negative effects of medications. When asked about what alternatives to drugs he might recommend to someone struggling with depression, he said that sometimes, just doing nothing will be helpful, since most mood problems clear up spontaneously in 12 to 14 weeks. He said that most are simply human problems, not "mental disorders," but real-life problems, like relationship conflicts or social issues. Although we did not discuss it extensively on the show, I would point out that skillful, drug-free therapy with TEAM CBT can sometimes help as well, and that recent research has confirmed rapid often dramatic mood improvements with individuals using the Feeling Great app, which has been entirely free to anyone since the summer of 2025.  Finally, we do not advise anyone to discontinue or modify the dosages of any medications you have been prescribed without consultation with your doctor. The information in the Feeling Good podcast is of a strictly educational nature, and is not intended as treatment or medical advice. We thank you for listening to today's shocking but incredibly important dialogue with one of the pioneers and champions of greater ethical integrity and transparency in the psychiatric profession. It is sad, indeed, that we don't have more visionary critical thinkers like Dr. David Healy! David (H), Rhonda, and David (B)

In this episode of Bowel Sounds, hosts Drs. Amber Hildreth and Jason Silverman talk to Dr. Saul Karpen, the inaugural chief scientific officer for the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University, Richmond, Va., where he is a professor of internal medicine and adjunct professor in pediatric medicine at the VCU School of Medicine. We talk about new genetic discoveries in biliary atresia and the future goals of research on this important pediatric liver topic.Learning objectivesDescribe the pathophysiology of biliary atresia Understand the importance of early screening and new tools to assist in early detection Examine the newly discovered genetic etiology to biliary atresiaLinks:Guidance for the Primary Care Provider in Identifying Infants with Biliary Atresia by 2-4 Weeks of Life: Clinical ReportBilitool.orgLiver-Restricted Deletion of the Biliary Atresia Candidate Gene PKD1L1 Causes Bile Duct Dysmorphogenesis and CiliopathyStravitz-Sanyal Institute for Liver Disease and Metabolic HealthAASLDPrevious Episodes Mentioned:Bill Balistreri- Neonatal CholestasisJorge Bezerra- Advances in Biliary AtresiaDisclosures:Dr. Karpen has a non-reimbursed consulting relationship with Ipsen as BOLD PIDr. Hildreth serves as a consultant and speaker for IpsenSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Featuring an interview with Dr Hanny Al-Samkari, including the following topics: VAYHIT1: A multicenter randomized, double-blind, Phase III trial evaluating ianalumab versus placebo in addition to first-line corticosteroids for patients with primary immune thrombocytopenia (ITP) (0:00) Secondary analysis results from VAYHIT3, a Phase II study of ianalumab for patients with primary ITP previously treated with at least 2 lines of therapy (8:15) Improved health-related quality of life and bleeding scores with the oral Bruton tyrosine kinase inhibitor rilzabrutinib in the open-label period of the multicenter Phase III LUNA 3 study for adults with ITP (12:23) Romiplostim for chemotherapy-induced thrombocytopenia in patients with colorectal, gastroesophageal and pancreatic cancer: A global Phase III randomized, placebo-controlled trial (16:01) CME information and select publications

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.CME information and select publications here.

Featuring perspectives from Prof Nicoletta Colombo and Dr Kathleen N Moore, including the following topics: Introduction (0:00) Promising Novel Agents and Strategies Under Investigation in Ovarian Cancer (2:35) Current Management of Newly Diagnosed and Relapsed/Refractory Ovarian Cancer(41:48) CME information and select publications

Prof Nicoletta Colombo and Dr Kathleen N Moore discuss the selection and sequencing of therapy for patients with ovarian cancer and summarize major advances in the treatment landscape over the past year.CME information and select publications here.

Host Dr. Andrew Pouw welcomes Drs. Gustavo De Moraes, Aakriti Shukla, and Simon John to discuss their team's work spanning the full arc of nicotinamide as a neuroprotection candidate for glaucoma, from bench to clinical trials. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Beef production continues restrained to keep prices up and packer losses as small as possible. 516K head produced last week, same as the previous week. Heading into spring this is keeping the beef supply tight and prices supported. We have the smallest beef herd since 1951 when there were half as many people in the country. That is not turning around anytime soon. Regarding current market prices, everything is going up. Ribeyes and strip loins will be leading prices higher for the next few weeks. Grind demand is strong and prices moving up as well. Chuck had a nice few weeks of declines, that is over, rounds never lost support and continue to move higher. I do think middle meats and thin meats, flanks, skirts, sirloin flap, will all be tight and expensive, already looking at Cinco de Mayo.  We are at the start of a steady move higher, I'd advise buy sooner, rather than later, waiting will cost you money. Keep well ahead of your needs, this market is going to be expensive and tight.Poultry production continues to run about 2% ahead of last year. Demand is good, production is strong, pricing is holding up, though wings declined a second week in a row. Boneless skinless breasts and tenders… holding steady. It's a good time to menu chicken. On the Avian flu front, its ugly. 23 new cases reported in the last week affecting 4.8Millioin birds, 4 million of those birds were egg layers. I'm not feeling good about spring migration.Soy markets continue to climb. Its been so long since we've seen a bull market in soy. Soy oil and canola oil, both moving higher with good export demand and higher biofuel usage. We may see this plateau in the next couple weeks, but right now, soy is on a tear. Corn and wheat… not so much . Still trading sideways and I don't see that changing.Pork bellies continue to march higher, today's close $153 up from last week $148. I don't think we are done by any stretch. Bacon will be going up. Contrary to rest of the pork complex, plenty of inventory, prices are good. Yes, menu pork.Butter took a huge run up this week. Thru Thursday's close on the CME butter is up 24! That's a big move. Barrel and block both up 3 but butter is the big mover. We'll see if the markets hold these recent gains, but for now all signs point to a higher dairy costs.Savalfoods.com | Find us on Social Media: Instagram, Facebook, YouTube, Twitter, LinkedIn

In this episode, Tracey Davidoff, MD and Joe Toscano, MD discuss the February 2026 Evidence-Based Urgent Care article, Urgent Care Evaluation and Management of Constipation02:18 Why Constipation Matters03:36 Three Patient Categories06:28 Constipation Myths07:19 X-rays And Docusate09:42 What Is Normal12:12 Red Flags And Mimics15:34 Rectal Exam Decisions17:08 Enemas And Disimpaction20:20 Urgent Care Logistics21:05 Constipation vs Pain23:34 Appendicitis Cautionary Tale24:42 Treatment Ladder Basics26:13 Polyethylene Glycol Power29:26 Stercoral Colitis30:46 Normal Bowel Habits31:55 Bottom Line Red Flags33:30 When Its Not Constipation36:27 Wrap Up and Next Topics???? Subscribers, take the CME test here.✅️ Not a subscriber? Join here!

Zach Mercurio, Ph.D., is a researcher, author, and speaker who specializes in purposeful leadership, mattering, meaningful work, and positive organizational psychology.He wrote "The Invisible Leader: Transform Your Life, Work, and Organization with the Power of Authentic Purpose." His forthcoming book, "The Power of Mattering: How Leaders Can Create a Culture of Significance," will be released by Harvard Business Review Press in 2025.Zach works with hundreds of organizations worldwide to forge purposeful leaders who enable mattering, motivation, well-being, and performance. Some of his clients include the U.S. Army, USA Wrestling, J.P. Morgan Chase, Delta Airlines, Marriott International, The Government of Canada, and The National Park Service.He also serves as one of author Simon Sinek's “Optimist Instructors.”Zach earned his Ph.D. in organizational development from Colorado State University where he serves as a Research and Teaching Fellow in the Department of Psychology's Center for Meaning and Purpose and as an Instructor in the Organizational Learning, Performance, and Change program.His research on meaningful work has been awarded by The Association for Talent Development, The Academy of Management, and The Academy of Human Resource Development.Zach lives in Fort Collins, CO with his wife, two sons, and two adopted dogs.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

We've had many conversations on Raise the Line about the challenges of health communication in today's world of information overload, but none of our guests have the kind of expertise Dr. Tesfa Alexander has acquired in a career that has taken him from Madison Avenue to the halls of government and academia. From guiding tobacco education research at the FDA to leading public health initiatives at MITRE, Dr. Alexander has developed a deep understanding of the science and strategy behind effective health communication. “Successful campaigns keep the long game in mind where you want to develop a lasting relationship with your target audience,” he tells host Lindsey Smith. That relationship needs to be built on understanding culture, beliefs, priorities and daily realities, and only then can you develop messaging that will resonate, he explains. Dr. Alexander also believes these relationships can be leveraged to help people sort out facts from misleading or inaccurate claims. “I strongly recommend shifting our focus from combating misinformation head on, and instead working with the communities who we are seeking to serve.” This fascinating look at communication science also covers: How stories drive belief; The importance of working with community partners who are trusted messengers;  The power of audience segmentation. Tune in as Dr. Alexander unpacks what it takes to influence beliefs, and ultimately behaviors, in an era defined by misinformation and institutional mistrust. Mentioned in this episode:Lerner Center for Public Health Advocacy If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Crain's residential real estate reporter Dennis Rodkin joins host Amy Guth top talk news from the local market, including a new poll that found housing costs now top crime as Chicago voters' biggest concern. Plus: American blames United's "reckless scheduling" for O'Hare woes, CME and Cboe shares rallied to record high as volumes surge on Iran war, Oak Brook retail center sold for $44 million and Chicago Fire FC breaks ground on new South Loop stadium. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.CME information and select publications here.

Struggling to balance a demanding medical career with a healthy marriage? It might be more common than you think. In this part one of two eye-opening episode of Succeed In Medicine podcast host Dr. Bradley Block interviews Dr. Michael F. Myers, as they delve into frequent issues in physician marriages, including communication gaps, workaholism, and using work as an escape from home tensions. Dr. Myers shares insights on recognizing when overwork crosses into avoidance, the impact of poor role models from past generations, and practical ways to transition from work mode to family presence. Key discussions include protecting couple time amid busy schedules, handling defensiveness in conversations, and fostering intentional dates or "grown-up time" away from kids. They also touch on generational shifts in medicine, where younger physicians prioritize life balance over endless dedication, and the importance of transparency about personal costs of overwork. Dr. Myers emphasizes treating marital communication as a skill to master, like medical training, and highlights resources like retreats for enrichment. Whether you're a physician navigating marital discord or supporting a partner in medicine, this episode offers compassionate guidance to prevent burnout at home, strengthen relationships, and model healthy dynamics for kids, setting the stage for part two next week. Three Actionable Takeaways: Protect Couple Time Intentionally: Schedule uninterrupted "grown-up time" daily e.g., 30 minutes post-work with no distractions like TV or phones, or bi-weekly dates even low-cost walks; train kids to respect boundaries to rebuild connection beyond co-parenting, reducing feelings of drifting apart. Create a Work-to-Home Transition Ritual: Build in buffer time after shifts, whether a commute unwind, quick run, or quiet moment to shift from decisiveness at work to presence at home; recognize when exhaustion is temporary and communicate needs to avoid guilt or resentment. Listen Without Defensiveness: When a spouse flags overwork or avoidance, pause and reflect instead of rationalizing; treat communication as a learnable skill like medicine, seeking resources like marital retreats or therapy to address root issues before they escalate to fights or disconnection. About the Show: Succeed In Medicine covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school! About the Guest: Dr. Michael F. Myers is a professor of clinical psychiatry and recent past vice president of education and director of training in the Department of Psychiatry and Behavioral Sciences at SUNY Downstate Health Sciences University in Brooklyn. He's a specialist in physician health and the author of many books, including "Physicians with Lived Experience: How Their Stories Offer Clinical Guidance" and "Doctors' Marriages: A Look at the Problems and Their Solutions." He lectures widely on stresses in medical training, burnout, moral injury, depression, substance use, PTSD, marital discord, and reducing stigma in medicine. Connect with Dr. Michael Myers: Website: https://www.michaelfmyers.com About the Host: Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physicians Want to be a guest? Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more! Socials: @physiciansguidetodoctoring on Facebook @physicianguidetodoctoring on YouTube @physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Featuring an interview with Dr Hanny Al-Samkari, including the following topics: Mechanism of action and toxicity of the monoclonal antibody ianalumab (0:00) Primary results from VAYHIT2, a randomized, double-blind Phase III trial of ianalumab with eltrombopag for patients with primary immune thrombocytopenia (ITP) after failure of first-line corticosteroid treatment (7:32) Mechanism of action and toxicity of the Bruton tyrosine kinase inhibitor rilzabrutinib (11:52) Reduction in corticosteroid use with rilzabrutinib and sustained response in adults with persistent or chronic ITP in the long-term extension period of the Phase III LUNA3 study (18:46) CME information and select publications

Send a textThere's a moment that many successful medical practices reach where something feels… off.Volume is up. The practice is growing. On paper, things look good—sometimes even great. And yet, the day-to-day experience feels harder than it used to. Communication takes more effort. Decisions feel heavier. Small issues seem to snowball faster than expected.Instead of growth feeling energizing, it starts to feel exhausting.That's the moment we're talking about today. Because growth is supposed to make things better, not more chaotic. And when success starts creating friction inside a practice, it's not a sign that something is wrong—it's a sign that the practice is changing.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: https://share.hsforms.com/1FMup6xLPSpeA8hB77caYQwd32sx?hsCtaAttrib=171926995377 Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Promo pricing available now: https://education.healtheps.com/offers/Ry3zfLYp/checkout?coupon_code=PHYSEDGE3000 Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

Featuring perspectives from Dr Hope S Rugo and Dr Sara M Tolaney, including the following topics: Introduction: Long-Term Outcomes with Antibody-Drug Conjugates (0:00) HER2-Positive Breast Cancer (8:02) HER2-Negative Breast Cancer (32:41) CME information and select publications

Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Sara M Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data with antibody-drug conjugates in the management of breast cancer.CME information and select publications here.

CME outage before first notice day sparks gold market manipulation fears as physical demand surges and East challenges Western price control. What are the odds that the world's largest gold and silver derivatives exchange suddenly experiences a “technical outage” right before first notice day? Questions on Protecting Your Wealth with Gold & Silver? Schedule a Strategy Call Here ➡️ https://calendly.com/itmtrading/podcastor Call 866-349-3310 

Comex Gold Delivery Was Discouraged From The Beginning With rumors swirling around the CME's latest "technical glitch" ahead of another delivery cycle, what we can say with certainty is what was revealed by some WikiLeaks cables about the formation of the COMEX gold market back in the 70s, and the true intention behind the system we currently have. David Morgan walks through the key document, and to find out more about this hidden piece of history, click to watch this video now! - To get access to David's fantastic research at “The Morgan Report” go to: https://www.themorganreport.com/membersportal/aff/go/ArcadiaEconomics - Join our free email list to be notified when a new video comes out: click here: https://arcadiaeconomics.com/email-signup/ - Follow Arcadia Economics on twitter at: https://x.com/ArcadiaEconomic - To get your copy of 'The Big Silver Short' (paperback or audio) go to: https://arcadiaeconomics.com/thebigsilvershort/ - #silver #silverprice #gold And remember to get outside and have some fun every once in a while!:) (URL0VD)Subscribe to Arcadia Economics on Soundwise

In this episode, Sam Ashoo, MD and T.R. Eckler, MD discuss the February 2026 Emergency Medicine Practice article, Emergency Department Diagnosis and Management of Acute Coronary Occlusion00:00 - Introduction & Welcome01:21 - Episode Overview: Acute Coronary Occlusion02:06 - Why This Topic Matters: Statistics & New Guidelines03:35 - Nomenclature: ACO vs STEMI/NSTEMI06:15 - Differential Diagnosis for STEMI07:41 - Pre-Hospital Care & EMS Role11:37 - Patient History & Presenting Symptoms12:28 - Physical Examination Findings14:54 - EKG: The Most Important Test17:00 - STEMI Definition & Criteria20:32 - STEMI Equivalents: Scarbosa Criteria22:40 - Smith Modified Scarbosa Criteria24:10 - Hyperacute T Waves25:30 - Posterior STEMI28:40 - De Winter Sign29:38 - Non-STEMI EKG Findings31:30 - AVR ST Elevation32:47 - Wellens Syndrome33:54 - Reciprocal ST Segment Changes36:15 - Inferior MI Patterns37:54 - Laboratory Testing39:51 - Imaging: Chest X-Ray & Echocardiography42:25 - Supplemental Oxygen: What the Evidence Shows44:50 - Analgesia & Pain Management46:35 - Pharmacotherapy: Aspirin & Antiplatelet Agents49:18 - Reperfusion Therapies & Thrombolytics53:05 - Cardiac Arrest in STEMI Patients53:55 - Closing Remarks & CME InformationSubscribers, take the CME test here.Emergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

CME outage before first notice day sparks gold market manipulation fears as physical demand surges and East challenges Western price control. What are the odds that the world's largest gold and silver derivatives exchange suddenly experiences a “technical outage” right before first notice day?Questions on Protecting Your Wealth with Gold & Silver? Schedule a Strategy Call Here ➡️ https://calendly.com/itmtrading/podcastor Call 866-349-3310

At 12:15 pm CT yesterday, CME Globex Metals and Natural Gas futures and options markets were halted. Metals trading resumed about 90 minutes later. The CME blamed it on technical issues. We report new drill results from White Gold and Spanish Mountain Gold. We have the latest corporate updates from Great Pacific Gold, Talisker Resources and Equinox Gold. This episode of Mining Stock Daily is brought to you by... Revival Gold is one of the largest pure gold mine developer operating in the United States. The Company is advancing the Mercur Gold Project in Utah and mine permitting preparations and ongoing exploration at the Beartrack-Arnett Gold Project located in Idaho. Revival Gold is listed on the TSX Venture Exchange under the ticker symbol “RVG” and trades on the OTCQX Market under the ticker symbol “RVLGF”. Learn more about the company at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠revival-dash-gold.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Vizsla Silver is focused on becoming one of the world's largest single-asset silver producers through the exploration and development of the 100% owned Panuco-Copala silver-gold district in Sinaloa, Mexico. The company consolidated this historic district in 2019 and has now completed over 325,000 meters of drilling. The company has the world's largest, undeveloped high-grade silver resource. Learn more at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠https://vizslasilvercorp.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Equinox has recently completed the business combination with Calibre Mining to create an Americas-focused diversified gold producer with a portfolio of mines in five countries, anchored by two high-profile, long-life Canadian gold mines, Greenstone and Valentine. Learn more about the business and its operations at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠equinoxgold.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Integra Resources is a growing precious metals producer in the Great Basin of the Western United States. Integra is focused on demonstrating profitability and operational excellence at its principal operating asset, the Florida Canyon Mine, located in Nevada. In addition, Integra is committed to advancing its flagship development-stage heap leach projects: the past producing DeLamar Project located in southwestern Idaho, and the Nevada North Project located in western Nevada. Learn more about the business and their high industry standards over at integraresources.com

What would you do if you opened your mail and saw a letter from the medical board? For many physicians, that moment triggers fear, shame, and a flood of worst-case scenarios. Even a single patient complaint can feel like your entire career is suddenly on the line. And because most of us were never trained on how medical board investigations actually work, the uncertainty can be overwhelming. In today's episode, I'm joined by Guillermo Beates, Esq., a seasoned healthcare attorney and partner at Friar Levitt, who works closely with physicians facing medical board investigations, licensing issues, audits, and administrative actions. Guillermo pulls back the curtain on a process that often feels mysterious, intimidating, and isolating—and explains what physicians really need to know to protect themselves and their careers. We talk honestly about why board investigations happen, what not to do if you're contacted, and how small missteps early on can snowball into much bigger problems. Most importantly, Guillermo shares a grounded, hopeful message: one investigation does not have to define your career. In this episode we're talking about: Common triggers for medical board investigations, including patient complaints, audits, and reports from other clinicians What different types of board notices mean, and how to "triage" them appropriately Why responding incorrectly (or not responding at all) can escalate a situation fast The risks of surrendering a license or DEA/CDS registration without legal guidance What consent orders are, and why they matter more than many physicians realize How investigations become public and what gets reported to the National Practitioner Data Bank Why fear and shame can push physicians to leave medicine prematurely, and why you don't have to Links for this episode: Frier Levitt - Professional Board Actions: https://www.frierlevitt.com/what-we-do/healthcare-law/professional-board-actions